MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Inflammatory Bowel Disease
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

6,452 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
6,452 works in the cohort · of 4,299,418page 80 of 130

Labels cover 21 of 6,452 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 6,452 of 6,452 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Epidemiology and Natural History of IBD in the Paediatric Age
Graziella Guariso, Marco Gasparetto, Andrew S. Day, Paul Henderson
2014· article· en· Gastroenterology Research and Practice· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
S857 Patient-Reported Outcomes of Response and Remission Following Guselkumab Induction Treatment as Measured by the Inflammatory Bowel Disease Questionnaire: Results Through Week 12 of the Phase 2 GALAXI 1 Study
David T. Rubin, Remo Panaccione, Geert D’Haens, Chenglong Han, Susana Gonzalez, Kathleen Weisel +7 more
2021· article· en· The American Journal of Gastroenterology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
What is the cancer risk in Crohnʼs disease?
Hugh James Freeman
2008· article· en· Inflammatory Bowel Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Mesalamine maintenance therapy for Crohn's disease
Brian G. Feagan, John WD McDonald
2001· letter· en· Gastroenterology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
Ustekinumab for the Treatment of Crohn’s Disease
Sara Keihanian, Sarah C. Glover
2014· article· en· The American Journal of Gastroenterology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
afffundunlabeled
Improvement of Transmural Inflammation With Adalimumab Versus Immunomodulator Maintenance Therapy in Pediatric Crohn’s Disease: Single-Center Prospective Evaluation Using the Pediatric Inflammatory Crohn’s Magnetic Resonance Enterography Index
Luca Scarallo, Hayley E. McKay, Rilla Schneider, Amanda Ricciuto, Thomas D. Walters, Mary‐Louise C. Greer +2 more
2024· article· en· Inflammatory Bowel Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations

How this was built: Screen · Findings · About